UC Irvine’s Gynecologic Oncology Division treats a full spectrum of gynecologic cancers, including ovarian, uterine, cervical, and vulvar cancers. The clinical schedule includes 2-4 half-day clinics, 2-4 half-day operating room blocks, and one half-day protected for administrative duties. Robotics are available, with Da Vinci (dV5 and Xi units) systems on-site, offering advanced minimally invasive surgeries.
The clinical team operates across multiple sites, including UCI Medical Center, Long Beach Memorial, and St. Joseph’s, with the potential addition of Fountain Valley. The division director will help coordinate care between these hospitals, ensuring efficient call coverage and clinical trial involvement. Infusion centers are available at the Irvine and Orange campuses for patients receiving chemotherapy.
Call duties are shared among five faculty members and fellows, with fellows taking the first call. The division director is expected to manage this call burden and address any ongoing staffing needs, particularly at Long Beach, where there is currently a gap in senior faculty coverage.
Research is a significant component of this position, with clinical trials and mentorship of junior faculty and fellows expected.
UC Irvine Health is renowned for clinical excellence and leading-edge research. As a faculty physician here, you'll work alongside top medical minds advancing patient care through innovation and discovery.
UCI is at the forefront of groundbreaking medical firsts like performing the world’s first lung transplantation and developing breast cancer drug Herceptin. Collaborate with pioneering researchers and physicians as you care for patients.
The Department of Obstetrics and Gynecology at the University of California, Irvine invites applications for a faculty position at the Associate or Full Professor level in the Health Sciences Clinical Professor Series to serve as the Division Director for the Division of Gynecologic Oncology.
This division is internationally known for its research and clinical expertise and maintains one of the most prestigious fellowship programs in the country. The Director will be nominated for the title of the Philip J. DiSaia Endowed Chair in Gynecologic Oncology and will lead the division in the development of programs in the NCI designate Chao Family Comprehensive Cancer Center, as well as various affiliate sites in the Southern California area.
The position will be recruited as a full-time appointment at the Associate or Full Professor level depending on qualifications. The successful candidate will have a proven record of research activity, a broad experience in the latest diagnostic, treatment, and surgical modalities in gynecologic oncology, as well as a commitment to education and experience in administrative leadership. The successful candidate will provide mentorship to junior faculty. They will oversee basic and health sciences research and will participate in strategic and financial planning for divisional growth. They will also have demonstrated efforts in diversity, equity, and inclusion within the workforce and the patient population we serve.
Responsibilities will include a clinical practice of the full range of gynecologic cancer surgery, chemotherapy, and ambulatory practice; supervision and teaching of medical students, residents, and fellows; participation in and mentorship of trainees in research activities (determined by the individual faculty members interest and expertise); as well as other general divisional and departmental services.
Candidates must possess an M.D. degree, California medical license (at time of start date), American Board of Obstetrics and Gynecology eligible or certified, and successful completion of sub-specialty training in Gynecologic Oncology with subsequent Specialty Board candidacy or certification.
Each year, more than 71,000 women in the United States are diagnosed with a cancer of the reproductive system. More than 26,000 women die of their disease, often because it wasn’t detected early enough.
Our UCI Health gynecologic cancer specialists take a holistic, proactive approach to diagnosing and treating women for all types of gynecologic diseases, including cancers of the ovaries, uterus, cervix, fallopian tubes, vulva and vagina. Our physicians work with you to develop a personalized plan of treatment.
Our team includes nationally-recognized experts in the diagnosis and treatment of cancers of the female reproductive system, including robot-assisted surgical techniques and HIPEC, a unique chemotherapy treatment used to destroy any lingering cancer cells left behind after surgery.
We work as a team with medical oncologists, radiation specialists and other physicians to ensure that you received the most exacting diagnosis and the most advanced care.
As part of the Chao Family Comprehensive Cancer Center, Orange County's only National Cancer Institute-designated comprehensive cancer center, our physicians also lead clinical trials that give our patients access to new therapies well before they are available elsewhere.
UCI Health gynecologic cancer specialists are integral members of the medical team that has kept UCI Medical Center ranked among U.S. News & World Report’s top 50 best hospitals for gynecology services over most of the last decade.
Advanced treatment: Our gynecologic oncologists use the latest surgical technologies — advanced robot-assisted surgery, laparoscopy and single-incision laparoscopic surgery — for cancers of the uterus, cervix and ovary.
Expertise: Our world-renowned surgeons provide expert treatment for advanced-stage and recurrent ovarian, fallopian tube and peritoneal cancers, including extensive cytoreduction, or debulking surgery.
We also offer our patients a unique treatment designed to kill ovarian cancer cells left behind after surgery. HIPEC, or hyperthermic intraperitoneal chemotherapy, involves bathing the abdominal cavity with a heated chemotherapy solution to eradicate any remaining microscopic cancer cells.
Personalized care: We believe in tailoring diagnosis and treatment plans to each patient to maximize survival and to provide the highest quality of life during and after treatment.
Conditions & Treatments
Our UCI Health gynecologic cancer team embraces the latest available technologies and therapies for diagnosing and treating women with all types of gynecological cancer.
Our specialists are internationally recognized for their work in minimally invasive and robot-assisted surgical techniques, cytoreductive surgery for advanced or recurrent ovarian cancer, fallopian tubes and primary peritoneal cancers.
We also perform fertility-preserving surgery for women with early-stage cervical cancer and manage the treatment of women with early-stage endometrial cancer who want to preserve their fertility.
Our specialists are experts in the use of chemotherapy, biological therapies and radiation therapy to treat women with all types of gynecologic cancers and cancer-related issues, including:
We also treat women at higher risk of developing certain gynecologic cancers. At our Ovarian Cancer Center, we offer the only high-risk ovarian cancer screening and survivorship program in Orange County. Called Ann's Clinic, it was developed in partnership with the Queen of Hearts Foundation, an Orange County nonprofit group formed by the children of Ann S. Dobbie, who died of ovarian cancer within six months of her diagnosis.
As international leaders in major cooperative research groups, our specialists also are able to offer our patients access to leading-edge treatments and therapies years before they are available to the general public.
Here at UCI Department of Medicine, we highly value diversity. Diversity is core to our ability to offer compassionate and culturally competent care in a variety of practice settings, to patients from all walks of life, addressing simple to complex healthcare needs, while working with others who embrace a broad variety of backgrounds, experience, and perspectives. We remain committed to advancing diversity, in its broadest sense, in our programs through recruitment, training, retention and mentoring. This, we believe, is vital to our ability to continue to achieve excellence in serving our richly diverse community through our discover, teach, and heal mission. If this collaborative, respectful, and inclusive approach speaks to you, I look forward to your selection of UCI Department of Medicine as your training program of choice.
-Alpesh Amin, MD, MBA, MACP, SFHM
https://www.ucihealth.org/medical-services/gynecologic-oncology